Skip to content
Galaxy Medicare logo

Galaxy Medicare

GML NSE
₹18.00 unchanged 0.00 (0.00%)
Market Cap
₹27.31 Cr

Galaxy Medicare (GML) share price was ₹18.00 at the 27 Oct 2026 close; market capitalisation ₹27.31 Cr; sector Healthcare. The share price fell 15.3% over the year to 27 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue fell 3.1% year on year to ₹21.27 Cr and net profit was ₹1.40 Cr, against ₹1.66 Cr a year earlier (compared with Mar 2025). Promoters held 73.36% of Galaxy Medicare in Sep 2026, up 0.38 percentage points from Mar 2026. Its Tapetide Score is 57/100 (Good) as of 28 Oct 2026.

Close 27 Oct 2026 ₹18.00 −3.90 −17.81% 1Y

Key Fundamentals

SMEHealthcare Equipment & SuppliesHealthcare
Market Cap
₹27.31 Cr
EBITDA
₹5.50 Cr
Return on Equity
8.47%
Debt to Equity
0.1
Book Value
₹22.83
EPS (TTM)
—
52W High
₹23.80
52W Low
₹15.15

Price-based figures as of 29 Oct 2026, 09:28 IST · TTM

Peer Comparison

Healthcare › Medical Equipment › Medical Equipment & Supplies

Poly Medicure
₹1,461.9047.0214,818 Cr4.770.24%10.18%13.33%2,115 Cr313 Cr
Fischer Medical Ventures
₹26.2469.051,717 Cr3.750.20%8.11%12.69%373 Cr24 Cr
Tarsons Products
₹306.60146.701,631 Cr2.570.66%2.26%4.82%468 Cr11 Cr
Q-Line Biotech
₹545.0025.831,271 Cr2.600.00%22.63%26.37%201 Cr34 Cr
Laxmi Dental
₹178.3531.79981 Cr4.030.00%10.83%11.51%289 Cr31 Cr
Hemant Surgical Industries
₹577.00—839 Cr5.350.00%13.22%19.52%——
Galaxy Medicare (this company)
₹18.00—27 Cr0.793.89%8.47%12.01%——
Median 7 companies₹306.6047.021,271 Cr3.750.20%10.18%12.69%373 Cr31 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

57 Good
Overall score

Data confidence 81/100

Category scores

Quality Average 50
Returns, margins, earnings quality 22% weight
Valuation Strong 76
Cheap vs sector & own history 24% weight
Growth Weak 40
Sales & profit trajectory 9% weight
Financial Health Good 61
Solvency, leverage, coverage 9% weight
Momentum Average 50
Trend strength, vol-adjusted 12% weight
Ownership Average 52
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Stock is trading at 0.63 times its book value
  • Company has been maintaining a healthy dividend payout of 19.2%

Weaknesses

2
  • The company has delivered a poor sales growth of 6.84% over past five years.
  • Company has a low return on equity of 13.5% over last 3 years.

Technical Indicators

Oscillators

Bullish

Bearish
0
Neutral
7
Bullish
2

Overall

Neutral

Bearish
6
Neutral
7
Bullish
6

Moving Averages

Bearish

Bearish
6
Neutral
0
Bullish
4

Growth Rate

Revenue Growth
2.48% lower than 3Y

change over 1 year

Net Income Growth
0% lower than 3Y

change over 1 year

Cash Flow Change
-60.58%

change over 1 year

EBITDA Margin Change
-5.7%

change over 1 year Operating margin 6.44% · Mar 2026

Quarterly Results

Particulars Sep 2024Mar 2025Sep 2025Mar 2026
Sales
17.24
21.96
18.73
21.27
Expenses
14.74
19.81
15.87
19.9
Operating Profit
2.5
2.15
2.86
1.37
OPM %
14.5%
9.79%
15.27%
6.44%
Other Income
0.55
0.52
0.33
0.98
Interest
0.38
0.31
0.11
0.16
Depreciation
0.25
0.25
0.3
0.25
PBT
2.42
2.11
2.78
1.94
Tax %
29.34%
21.8%
27.34%
27.32%
Net Profit
1.71
1.66
2.02
1.4
EPS (₹)
1.44
1.4
1.33
0.92
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2021Mar 2023Mar 2024Mar 2025Mar 2026
Sales
28.57
30.94
35.84
38.86
39.77
Expenses
26.41
28.59
30.87
34.16
35.45
Operating Profit
2.16
2.35
4.97
4.7
4.32
OPM %
7.56%
7.6%
13.87%
12.09%
10.86%
Other Income
0.5
1.72
1.18
1.07
1.22
Interest
0.8
0.95
0.94
0.74
0.28
Depreciation
0.82
1.12
0.48
0.5
0.55
PBT
1.04
2
4.73
4.53
4.71
Tax %
30.77%
21.5%
21.56%
25.61%
27.39%
Net Profit
0.72
1.57
3.71
3.37
3.42
EPS (₹)
2.57
5.16
3.13
2.84
2.25
Div. Payout %
9.72%
0%
0%
26.39%
31.05%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2021Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
2.8
3.04
11.86
11.86
15.17
Reserves
12.88
14.78
9.51
12.29
25.17
Borrowings
8.78
9.15
8.12
4.61
4.2
Other Liabilities
5.44
5.34
3.05
2.73
4.23
Total Liabilities
29.9
32.31
32.54
31.49
48.77
Fixed Assets
13.95
14.57
14.41
14.13
15.03
CWIP
0.2
0.06
0
0
0
Investments
2.98
2.69
3.11
2.82
2.87
Other Assets
12.77
14.99
15.02
14.54
30.87
Total Assets
29.9
32.31
32.54
31.49
48.77
Figures in ₹ Crores

Cash Flow

Particulars Mar 2021Mar 2023Mar 2024Mar 2025Mar 2026
Operating
5.56
3.65
2.71
4.49
1.77
Investing
-4.46
-1.91
-0.65
0.32
-13.9
Financing
-1.11
-1.8
-2.08
-4.72
12.09
Net Cash Flow
0
-0.07
-0.03
0.09
-0.05
Free Cash Flow
1.09
2.9
2.5
4.37
0.21
CFO/OP
273
170
76
118
67
Figures in ₹ Crores

Ratios

Particulars Mar 2021Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
93.26
107
74.65
64.72
69.93
Inventory Days
73.9
101
124
84.75
98.62
Days Payable
102
91.77
32.29
22.05
43.69
Cash Conversion Cycle
65.5
116
166
127
125
Working Capital Days
0.51
36.1
56.93
68.94
94.62
ROCE %
—
—
18.53%
17.72%
13.86%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Galaxy Medicare insights

55 extracted metrics + investor summaries across FY21–FY26.

Shareholding Pattern

Promot.73.36%Others2.68%Public23.96%As ofSep 2026

Documents

Frequently Asked Questions about Galaxy Medicare

What does Galaxy Medicare Ltd do?
Incorporated in July 1992, Galaxy Medicare Limited manufactures and exports medical devices, POP bandages, and surgical dressings in India.[1]
Where is Galaxy Medicare Ltd (GML) listed?
Galaxy Medicare Ltd trades as GML on the NSE.
Which sector does Galaxy Medicare Ltd belong to?
Galaxy Medicare Ltd is classified under the Healthcare sector, in the Medical Equipment industry.
What is the market capitalisation of Galaxy Medicare Ltd?
Galaxy Medicare Ltd has a market capitalisation of ₹27.31 Cr as of 29 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Galaxy Medicare Ltd?
Over the last 52 weeks Galaxy Medicare Ltd has traded between ₹15.15 and ₹23.8 as of 29 Oct 2026.
Does Galaxy Medicare Ltd pay dividends?
Galaxy Medicare Ltd has a dividend yield of 3.89%.
What is the Return on Equity (ROE) of Galaxy Medicare Ltd?
Galaxy Medicare Ltd reported a return on equity of 8.47%. Its debt-to-equity ratio is 0.10.

Company Information

Incorporated in July 1992, Galaxy Medicare Limited manufactures and exports medical devices, POP bandages, and surgical dressings in India.[1]

Website galaxy.in
Listed 2025-09-17
Face Value ₹ 10
Shares Outstanding 1,51,71,983

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/GML.md for Galaxy Medicare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Healthcare Equipment stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month